Patents Represented by Attorney Paul G. Alloway
  • Patent number: 8029796
    Abstract: The present invention provides synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: October 4, 2011
    Assignee: Genzyme Corporation
    Inventor: Charles A. Nicolette